Advisory panel recommends FDA to allow the continued use of ESA labels - The Money Times PDF Print
The Money TimesThe current prescribing guidelines for darbepoetin use among chronic kidney disease patients not on dialysis was highly endorsed by the FDA's Cardiovascular

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.